PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- Tridiuum, the leading provider of digital health solutions for accelerating behavioral and medical care integration, today announced that Mary Anne Mason, a leading healthcare industry executive, has joined its Board as an Independent Director.A successful entrepreneur with more

SOUTH PLAINFIELD, N.J., Oct. 15, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2019 financial results and provide an update on the company's business and outlook on Tuesday, October 29, 2019 at

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company's financial results for the quarter ended September 30, 2019, and provide a general business overview, on Tuesday

TEL AVIV, Israel, Oct. 15, 2019 /PRNewswire/ -- MaxQ AI, the industry-leading medical diagnostic AI company, today announced that the company's Accipio intracranial hemorrhage (ICH) and stroke software will be in

TEL AVIV, Israel, Oct. 15, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical study evaluating THX-210, a proprietary novel pharmaceutical preparation containing non-psychoactive cannabinoid canna

SAN DIEGO and PENNINGTON, N.J., Oct. 15, 2019 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of new data in Clinical Cancer Research which highlighted TAVO™ (intratumoral plasmid IL-12 with electropor

CLEVELAND, Oct. 15, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the third quarter 2019. The preliminary results have not been audited and are subject to change.

WINNIPEG, Oct. 15, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILETM-Heart Failure (SMILE-HF) Clinical Trial which was presented at the recent Heart Failure Society of America ("HFSA") conference in

SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, president and chief executive officer, will present at the Solebury Trout Private Company Showcase, on Friday, October 18

OAKLAND, CA and TORONTO, Oct. 15, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), a California-focused, vertically integrated cannabis enterprise, announced today that key executives, members of the Board of Directors and insiders, have entered into an additional, extended